Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

BUMETANIDE

BUMETANIDE

Standard Dose
0.25MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BUMETANIDE is listed in Drugs@FDA under application 219116 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BUMETANIDE Form and strength INJECTABLE;INJECTION - 0.25MG/ML Sponsor QILU PHARM HAINAN Submission history Latest submission status date: 2025-06-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUMETANIDE is listed in Drugs@FDA under application 219116 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BUMETANIDE Form and strength INJECTABLE;INJECTION - 0.25MG/ML Sponsor QILU PHARM HAINAN Submission history Latest submission status date: 2025-06-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.